ProPhase Labs Q4 2021 COVID-19 testing volumes surpass previous levels 2022/01/13 13:52:03 Seeking Alpha
ProPhase Labs (PRPH) announces that testing volumes exceeded well over 300,000 PCR COVID-19 tests during Q4 2021
ProPhase Labs (NASDAQ:PRPH) Earns Buy Rating from Analysts at HC Wainwright 2021/12/22 06:24:42 Dakota Financial News
Investment analysts at HC Wainwright began coverage on shares of ProPhase Labs (NASDAQ:PRPH) in a report issued on Monday, Price Targets.com reports. The brokerage set a buy rating and a $12.00 price target on the stock. HC Wainwrights target price indicates a potential upside of 52.09% from the stocks current price. A number of other 
ProPhase Labs Continues to Build Strong Leadership with Key Promotions and Additions to Management Team 2021/12/16 13:30:00 Intrado Digital Media
Precision Medicine division adds Industry Veteran Sam A. Beeler as Chief Strategy Officer; Diagnostics Division Promotes Alice Lioi and Jason Karkus to EVP and Co-Chief Operating Officers and Sergio Miralles to EVP/ Chief Information Officer
State Street Corp Invests $86,000 in ProPhase Labs, Inc. (NASDAQ:PRPH) 2021/12/13 09:12:45 Transcript Daily
State Street Corp purchased a new position in shares of ProPhase Labs, Inc. (NASDAQ:PRPH) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund purchased 13,795 shares of the companys stock, valued at approximately $86,000. State Street Corp owned 0.09% of ProPhase Labs at the end of 
ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Sold by Northern Trust Corp 2021/12/06 09:06:51 Dakota Financial News
Northern Trust Corp trimmed its stake in ProPhase Labs, Inc. (NASDAQ:PRPH) by 42.9% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 19,850 shares of the companys stock after selling 14,939 shares during the quarter. Northern Trust Corp owned approximately 0.13% of ProPhase Labs worth 
PROPHASE LABS, INC. ANNOUNCES INDUCEMENT AWARD UNDER NASDAQ LISTING RULE 5635(C)(4) 2021/11/23 21:15:00 Intrado Digital Media
GARDEN CITY, NY, Nov. 23, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, today announced that it has granted an inducement award to a new employee.
ProPhase Labs'' (PRPH) CEO Ted Karkus on Q3 2021 Results - Earnings Call Transcript 2021/11/12 22:00:32 Seeking Alpha
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2021 2021/11/12 13:30:00 Intrado Digital Media
Company to hold a conference call November 12 , 2021 at 11:00 AM ET
ProPhase Labs to Present at the Benzinga Healthcare Small Cap Conference 2021/09/22 12:30:00 Intrado Digital Media
GARDEN CITY, NY, Sept. 22, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at the Benzinga Healthcare Small Cap Conference, which is being held virtually from September 29 30, 2021.
ProPhase Labs Announces $6 Million Stock Repurchase Program 2021/09/08 12:30:00 Intrado Digital Media
Garden City, NY, Sept. 08, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company, today announced that its Board of Directors has authorized the repurchase of up to $6 million in ProPhase common stock.